Fennec (FENC) has expanded its leadership team with the appointment of Adrian Haigh as COO. Adrian has been a board member of Fennec since 2014 and with his appointment to the management team of Fennec will step down as board member. Adrian recently retired from PTC Therapeutics (PTCT) where his last role was senior VP and head of international.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FENC:
- Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
- Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023
- Fennec management to meet with Craig-Hallum
- Fennec Announces Results of Annual Meeting
- Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients